Speakers
Date: Oct. 28-30, 2005 Venue: Shanghai Worldfield Convention Hotel, China
Date: Oct. 31-Nov.1, 2005 Venue:
Dalian Furama Hotel, China
Currently, about 18 workshops have been proposed by organizers. You can click here to find suitable session for your speech. First Day will have two Nobel Prize Laureates to offer keynote lectures in suitable sessions.
However, you are welcomed to propose topic of the conference, or propose a session that you think is important in the Workshop. If you are ready to do so, please click here to send us a proposal and the speakers you are planning to invite, then we will forward your suggestions to the advisory committee for evaluation and will sooner inform you to move forward.
You may register for speech. For detail information, please check the guideline for each session by click here.
Please consider contributing to this very important meeting through your participation in the podium program.
Extra Benefits for speakers
Beside one page published on the annual booklet of IDDST and 30 minute talk at the event, a registered speaker will be free to access to the grand ceremony, Nobel Lectures, all scientific workshops, posters, exhibition, entrainment events, art gallery from celebrity, network with more than 1000 attendees and tours in Shanghai and Dalian.
Please take this great honor and wonderful opportunity, |
 |
For further information contact :
Dr. Xiaodan Mei
President of WHTS.
Tel/Fax: (O)0086-411-84799619
Email: xmei@whts.org
Ms. Annie Sun
IDDST Program Coordinator
26 Gaoneng Street, Room 405,
Dalian High-tech Zone,
Dalian, LN 116025, China
Tel: (O)0086-411-84799639
Fax: (O)0086-411-84799606
E-mail: annie@whts.org
Submit abstract of your speech :
Confirmed Keynote Speakers |
| Dr. K. Barry Sharpless, The Nobel Prize in Chemistry, 2001 Dr. Rudolph A. Marcus, The Nobel Prize in Chemistry, 1992 |
Tentatively Confirmed Speakers |
Dr. Arti C Patel, Director, Global Health Development, CTIS, Inc., Canad Dr. Einar M. Sigurdsson, Assistant Professor, Millhauser Laboratories, New York University School of Medicine, USA Dr. Peter Lassota, Senior Scientist, Novartis Pharmaceuticals Corporation, USA Dr. Patricia LoRusso, Professor, Head of Combinatorial Chemistry F. Hoffmann-La Roche Ltd, USA Dr. Claudio Cavasotto, Senior Research Scientist, Molsoft LLC, USA Dr. Shahriar Mobashery, Chair, Navari Family Chair in Life Sciences, Department of Chemistry and Biochemistry, University of Notre Dame, USA Dr. Dmitry Samarsky, Director of Technology Development, Dharmacon Inc., USA Dr. Anthony Manning, Vice-President & Global Head, Inflammation, Autoimmunity & Transplantation Research, Hoffman La-Roche, Inc, Roche Palo Alto, LLC, USA Dr. Linda Penn, Editor, Division of Cellular and Molecular Biology, Ontario Cancer Institute, Canada Dr. Michael McManus, Head, University of California, San Francisco, Diabetes Center, USA Dr. Bin Liu, Assistant Professor, Department of Anesthesia, UCSF Comprehensive Cancer Center, USA Dr. Xavier Barril, Senior Computational Chemist, Vernalis (Cambridge) Biotech Company, UK Dr. Martin McMahon, Professor, Cancer Research Institute, USA Dr. Rik Derynck, Professor, University of California, San Francisco, USA Dr. Biao He, Assistant Professor, Cancer Center, University of California, San Francisco, USA Dr. Srikumar Chellappan, Associate Professor, Drug Discovery Program H. Lee Moffitt Cancer Center and Research Institute, USA Dr. Rosemary Akhurst, Professor, Mt Zion Cancer Research Institute, University of California at San Francisco, USA Dr. Sylva Petrocchi, Assistant Professor, Research Institute for Genetic and Human Therapy, Italy Dr. Margret Hoehe, Head, Genetic Variation, Haplotypes & Genetics of Complex Disease, Germany Dr. Konrad Bleicher, Head, Combinatorial Chemistry F. Hoffmann-La Roche Ltd Pharmaceuticals, Division, Lead Generation, Switzerland Dr. David Jablons, Associate Professor, UCSF Medical Center, San Francisco, USA Dr. Perry B. Hackett, Chief Science Officer, Discovery Genomics, Inc., USA Dr. Colin Collins, Associate Professor, University of California, San Francisco Comprehensive Cancer Center, USA Dr. George J Kontoghiorghes, Director, Metalloprotein Research Group, King's College London, London, UK Dr. Chafiq Hamdouchi, Principal Research Scientist, Lilly Research LaboratoriesA Division of Eli Lilly and Company, Lilly Corporate Center, USA Dr. Ruben Abagyan, Professor, Department of Molecular Biology, The Scripps Research Institute, USA Dr. Dean Felsher, Professor, Division of Oncology, Stanford University, USA Dr. Fillit, Howard, Executive Director, The Institute for the Study of Aging (ISOA), USA Dr. S Thayumanavan, Assistant Professor, University of Massachusetts Amherst, USA Dr. Timothy A Haystead, Associate Professor, Duke University Medical Center, USA Dr. R. Kip Guy, Assistant Professor, University of California, San Francisco, USA Dr. Nevena Veljkovic, Associate Professor, Institute of Nuclear Sciences VINCA, Yugoslavia Dr. Toni Wozniak, Professor, Hudson-Webber Cancer Research Center, USA Dr. Annette Kaiser, Professor, Biology Department, German University in Cairo, Egypt Dr. Jawed Fareed, Director, Departments of Pathology and Pharmacology, Loyola University Medical Center, Maywood, USA Dr. Peter Laggner, Professor, Institute of Biophysics and X-ray Structure Research, Australia Dr. Jeff Chen , Principal Scientist, CR&D, Amgen Inc.USA Dr. Judith Maria Rollinger, Professor, Institute of Pharmacy, Department of Pharmacognosy Leopold-Franzens-University, Austria Dr. Andrew Leach, Professor, Medicines Research Centre, Glaxo Wellcome Research & Development, U.K. Dr. Anton Filikov, Principal Investigator, Informatics & Modeling, ArQule Inc. USA Dr. Stephen Michnick, Associate Professor, Canada Research Chair in Integrative Genomics, Canada Dr. Tudor Oprea, Professor, Division of Biocomputing, University of New Mexico School of Medicine Dr. Wolfgang A. Schulz, Research Director, Dept. of Urology, Heinrich Heine University, Germany |